Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study tests a new drug called GR1802 in 228 adults with severe chronic sinusitis and nasal polyps. The goal is to see if it can shrink polyps, ease congestion, and reduce the need for surgery or steroid pills. Participants receive injections every two weeks for 13 months and…